Search Results 91-100 of 16690 for Lou Gehrig's disease

1. Neuromuscular Diseases - Department of Neurology - Mayo Clinic Research

   Mayo Clinic's Neurology Department investigators study motor neuron diseases, including ALS (Lou Gehrig's disease), peripheral neuropathies and myopathies.

2. Overview - Regenerative Neurobiology Lab - Mayo Clinic Research

   Spinal cord injury. Peripheral nerve injury. Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. Chemotherapy-induced peripheral neuropathy. The ...

3. Joel Streed | Mayo Clinic News Network - Page 61 of 170

   More than 15,000 Americans are living with Lou Gehrig's disease, also called ... (ALS), according to the Centers for Disease Control and Prevention.

4. Experimental Antisense Oligonucleotide Treatment for Amyotrophic Lateral Sclerosis With an arg15leu Pathogenic Variant in CHCHD10. - Mayo Clinic

   ... disease severity in a single ALS participant. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

5. A Study of Deep Phenotyping in Patients With ALS - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study ...

6. HEALEY ALS Platform Trial - Mayo Clinic

   ... ALS. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

7. A Study of the Safety of Mesenchymal Stem Cells for Treatment of One Patient with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   ... (ALS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

8. A Trial to Evaluate the Efficacy and Safety of Reldesemtiv in Patients with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   ... (ALS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

9. A Study to Evaluate the Performance of a Diagnostic Test for Amyotrophic Lateral Sclerosis - Mayo Clinic

   ... (ALS) or another neurodegenerative diseases ... Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

10. A Study to Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    ... disorder or dementia which would preclude evaluation of symptoms. Has a clinically significant medical condition (other than ALS) including the following ...